Novel Protein Glycan Side-Chain Biomarker and Risk of Incident Type 2 Diabetes Mellitus
Authors:
- 1 June 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 35 (6) , 1544-1550
Abstract
Objectives—: Enzymatically glycosylated proteins partake in multiple biological processes, including glucose transport and inflammation. We hypothesized that a novel biomarker (GlycA) of N -acetyl methyl groups originating mainly from N -acetylglucosamine moieties of acute-phase glycoproteins is related to incident type 2 diabetes mellitus and compared it with high-sensitivity C-reactive protein. Approach and Results—: In 26 508 initially healthy women free of diabetes mellitus, baseline GlycA and high-sensitivity C-reactive protein were quantified by nuclear magnetic resonance spectroscopy and immunoturbidimetry, respectively. During median follow-up of 17.2 years, 2087 type 2 diabetes mellitus cases occurred. In Cox models with adjustment for age, race, smoking, alcohol, activity, menopausal status, hormone use, family history, and body mass index, quartile 4 versus 1 hazard ratios and 95% confidence intervals were 2.67 (2.26–3.14) for GlycA and 3.93 (3.24–4.77) for high-sensitivity C-reactive protein; both P trend P trend P trend=0.10) and 2.57 (2.09–3.16; P trend<0.0001), respectively. Conclusions—: Our finding of an association between a consensus glycan sequence common to a host of acute-phase reactants and incident type 2 diabetes mellitus provides further support for inflammation in the development of type 2 diabetes mellitus. Additional studies exploring the role of enzymatic glycosylation in the prevention of type 2 diabetes mellitus are warranted. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00000479.Keywords
This publication has 24 references indexed in Scilit:
- Stratifying Type 2 Diabetes Cases by BMI Identifies Genetic Risk Variants in LAMA1 and Enrichment for Risk Variants in Lean Compared to Obese CasesPLOS Genetics, 2012
- A systematic approach to protein glycosylation analysis: a path through the mazeNature Chemical Biology, 2010
- Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional interventionDiabetes, Metabolic Syndrome and Obesity, 2010
- Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycansGlycobiology, 2010
- An association between Type 2 diabetes and α1‐antitrypsin deficiencyDiabetic Medicine, 2008
- Impaired activity of serum alpha-1-antitrypsin in diabetes mellitusDiabetes Research and Clinical Practice, 2007
- Ferritin and Transferrin Are Both Predictive of the Onset of Hyperglycemia in Men and Women Over 3 YearsDiabetes Care, 2006
- Altered glycosylation of α1-acid glycoprotein in patients with inflammation and diabetes mellitusClinica Chimica Acta, 2003
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Assignment of resonances for ‘acute‐phase’ glycoproteins in high resolution proton NMR spectra of human blood plasmaFEBS Letters, 1987